SYK inhibitors
The application provides methods of treating or reducing thrombocytopenia, leukopenia, anemia, or neutropenia in a patient in need thereof, comprising the step of administering an effective amount of a compound selected from Compounds 1-6, disclosed herein.
1. A method of treating or reducing aplastic anemia in a patient in need thereof, comprising administering to the patient an effective amount of a compound selected from:
or a pharmaceutically acceptable salt thereof.
2. The method of claim 1 , wherein compound is
or a pharmaceutically acceptable salt thereof.
3. The method of claim 1 , wherein compound is
or a pharmaceutically acceptable salt thereof.
4. The method of claim 1 , wherein compound is
or a pharmaceutically acceptable salt thereof.
5. The method of claim 1 , wherein compound is
or a pharmaceutically acceptable salt thereof.
6. The method of claim 1 , wherein compound is
or a pharmaceutically acceptable salt thereof.